IBDEI1DO ; ; 04-FEB-2020
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 04, 2020
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,22022,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22022,1,3,0)
 ;;=3^Urethritis, nonspec
 ;;^UTILITY(U,$J,358.3,22022,1,4,0)
 ;;=4^N34.1
 ;;^UTILITY(U,$J,358.3,22022,2)
 ;;=^5015655
 ;;^UTILITY(U,$J,358.3,22023,0)
 ;;=R33.9^^99^1122^17
 ;;^UTILITY(U,$J,358.3,22023,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22023,1,3,0)
 ;;=3^Urinary Retention,Unspec
 ;;^UTILITY(U,$J,358.3,22023,1,4,0)
 ;;=4^R33.9
 ;;^UTILITY(U,$J,358.3,22023,2)
 ;;=^5019332
 ;;^UTILITY(U,$J,358.3,22024,0)
 ;;=N34.2^^99^1122^16
 ;;^UTILITY(U,$J,358.3,22024,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22024,1,3,0)
 ;;=3^Urethritis, other
 ;;^UTILITY(U,$J,358.3,22024,1,4,0)
 ;;=4^N34.2
 ;;^UTILITY(U,$J,358.3,22024,2)
 ;;=^88231
 ;;^UTILITY(U,$J,358.3,22025,0)
 ;;=R32.^^99^1122^18
 ;;^UTILITY(U,$J,358.3,22025,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22025,1,3,0)
 ;;=3^Urinary incontinence, unspec
 ;;^UTILITY(U,$J,358.3,22025,1,4,0)
 ;;=4^R32.
 ;;^UTILITY(U,$J,358.3,22025,2)
 ;;=^5019329
 ;;^UTILITY(U,$J,358.3,22026,0)
 ;;=N39.0^^99^1122^19
 ;;^UTILITY(U,$J,358.3,22026,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22026,1,3,0)
 ;;=3^Urinary tract infect, site not specified
 ;;^UTILITY(U,$J,358.3,22026,1,4,0)
 ;;=4^N39.0
 ;;^UTILITY(U,$J,358.3,22026,2)
 ;;=^124436
 ;;^UTILITY(U,$J,358.3,22027,0)
 ;;=B35.6^^99^1122^6
 ;;^UTILITY(U,$J,358.3,22027,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22027,1,3,0)
 ;;=3^Tinea Cruris
 ;;^UTILITY(U,$J,358.3,22027,1,4,0)
 ;;=4^B35.6
 ;;^UTILITY(U,$J,358.3,22027,2)
 ;;=^119711
 ;;^UTILITY(U,$J,358.3,22028,0)
 ;;=R00.0^^99^1122^1
 ;;^UTILITY(U,$J,358.3,22028,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22028,1,3,0)
 ;;=3^Tachycardia,Unspec
 ;;^UTILITY(U,$J,358.3,22028,1,4,0)
 ;;=4^R00.0
 ;;^UTILITY(U,$J,358.3,22028,2)
 ;;=^5019163
 ;;^UTILITY(U,$J,358.3,22029,0)
 ;;=K08.89^^99^1122^2
 ;;^UTILITY(U,$J,358.3,22029,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22029,1,3,0)
 ;;=3^Teeth & Supporting Structure Disorders (Toothache)
 ;;^UTILITY(U,$J,358.3,22029,1,4,0)
 ;;=4^K08.89
 ;;^UTILITY(U,$J,358.3,22029,2)
 ;;=^5008467
 ;;^UTILITY(U,$J,358.3,22030,0)
 ;;=I83.91^^99^1123^5
 ;;^UTILITY(U,$J,358.3,22030,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22030,1,3,0)
 ;;=3^Varicose veins, asympt, of rt lwr extr
 ;;^UTILITY(U,$J,358.3,22030,1,4,0)
 ;;=4^I83.91
 ;;^UTILITY(U,$J,358.3,22030,2)
 ;;=^5008020
 ;;^UTILITY(U,$J,358.3,22031,0)
 ;;=I83.92^^99^1123^4
 ;;^UTILITY(U,$J,358.3,22031,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22031,1,3,0)
 ;;=3^Varicose veins, asympt, of lft lwr extr
 ;;^UTILITY(U,$J,358.3,22031,1,4,0)
 ;;=4^I83.92
 ;;^UTILITY(U,$J,358.3,22031,2)
 ;;=^5008021
 ;;^UTILITY(U,$J,358.3,22032,0)
 ;;=I83.93^^99^1123^3
 ;;^UTILITY(U,$J,358.3,22032,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22032,1,3,0)
 ;;=3^Varicose veins, asympt, of biltrl lwr extre
 ;;^UTILITY(U,$J,358.3,22032,1,4,0)
 ;;=4^I83.93
 ;;^UTILITY(U,$J,358.3,22032,2)
 ;;=^5008022
 ;;^UTILITY(U,$J,358.3,22033,0)
 ;;=H54.7^^99^1123^7
 ;;^UTILITY(U,$J,358.3,22033,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22033,1,3,0)
 ;;=3^Visual loss, unspec
 ;;^UTILITY(U,$J,358.3,22033,1,4,0)
 ;;=4^H54.7
 ;;^UTILITY(U,$J,358.3,22033,2)
 ;;=^5006368
 ;;^UTILITY(U,$J,358.3,22034,0)
 ;;=R53.1^^99^1123^8
 ;;^UTILITY(U,$J,358.3,22034,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,22034,1,3,0)
 ;;=3^Weakness
 ;;^UTILITY(U,$J,358.3,22034,1,4,0)
 ;;=4^R53.1
